Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival.
Brian Sandeep DeAhsan S FarooqiKyle G MitchellEthan Bernard LudmirJeff LewisWaree RinsurongkawongVadeerat RinsurongkawongJiun-Kae Jack LeeStephen G SwisherDon L GibbonsJianjun ZhangXiuning LeYasir Y ElaminDaniel R GomezMatthew S NingSteven Hsesheng LinZhongxing LiaoJoe Y ChangAra A VaporciyanJohn Victor HeymachMara B AntonoffSaumil J GandhiPublished in: JCO precision oncology (2023)
mutations were associated with longer OS among oligometastatic patients treated with comprehensive LCT in addition to systemic therapy.